Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice
- PMID: 10698076
- DOI: 10.1097/00004647-200002000-00020
Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice
Abstract
An in situ mouse brain perfusion model predictive of passive and carrier-mediated transport across the blood-brain barrier (BBB) was developed and applied to mdr1a P-glycoprotein (Pgp)-deficient mice [mdr1a(-/-)]. Cerebral flow was estimated from diazepam uptake. Physical integrity of the BBB was assessed with sucrose/inulin spaces; functional integrity was assessed with glucose uptake, which was saturable with a Km of approximately 17 mmol/L and Vmax of 310 mmol x 100 g(-1) x min(-1). Brain uptake of a Pgp substrate (colchicine) was significantly enhanced (two- to fourfold) in mdr1a(-/-) mice. These data suggest that the model is applicable to elucidating the effects of efflux transporters, including Pgp, on brain uptake.
Similar articles
-
Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.Pharm Res. 2001 Jul;18(7):957-63. doi: 10.1023/a:1010984110732. Pharm Res. 2001. PMID: 11496955
-
Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood-brain barrier in the mouse.Eur J Pharm Sci. 2006 Feb;27(2-3):167-74. doi: 10.1016/j.ejps.2005.09.009. Epub 2005 Nov 2. Eur J Pharm Sci. 2006. PMID: 16263252
-
The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice.Br J Pharmacol. 1999 Oct;128(3):563-8. doi: 10.1038/sj.bjp.0702804. Br J Pharmacol. 1999. PMID: 10516633 Free PMC article.
-
Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice.J Vet Pharmacol Ther. 2009 Feb;32(1):87-96. doi: 10.1111/j.1365-2885.2008.01007.x. J Vet Pharmacol Ther. 2009. PMID: 19161460
-
In situ mouse carotid perfusion model: glucose and cholesterol transport in the eye and brain.J Cereb Blood Flow Metab. 2008 Aug;28(8):1449-59. doi: 10.1038/jcbfm.2008.34. Epub 2008 Apr 30. J Cereb Blood Flow Metab. 2008. PMID: 18446168
Cited by
-
Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.Pharm Res. 2001 Jul;18(7):957-63. doi: 10.1023/a:1010984110732. Pharm Res. 2001. PMID: 11496955
-
Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats.Br J Pharmacol. 2003 Apr;138(7):1367-75. doi: 10.1038/sj.bjp.0705150. Br J Pharmacol. 2003. PMID: 12711638 Free PMC article.
-
On the rate and extent of drug delivery to the brain.Pharm Res. 2008 Aug;25(8):1737-50. doi: 10.1007/s11095-007-9502-2. Epub 2007 Dec 5. Pharm Res. 2008. PMID: 18058202 Free PMC article. Review.
-
How to measure drug transport across the blood-brain barrier.NeuroRx. 2005 Jan;2(1):15-26. doi: 10.1602/neurorx.2.1.15. NeuroRx. 2005. PMID: 15717054 Free PMC article. Review.
-
Safety and pharmacological characterization of the molecular tweezer CLR01 - a broad-spectrum inhibitor of amyloid proteins' toxicity.BMC Pharmacol Toxicol. 2014 Apr 16;15:23. doi: 10.1186/2050-6511-15-23. BMC Pharmacol Toxicol. 2014. PMID: 24735982 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
